Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year. Amid COVID-19 pandemic, the company
Eli Lilly (LLY) reports Q1 2020 earnings results
Categories
pharmaceuticals
Johnson & Johnson mentioned COVID 80 times during earnings call, vs. Abbott’s 16
Global pharma giants Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) announced their earnings for Q1 2020 last week. Despite
Biofrontera AG (NASDAQ: BFRA) Q4 2019 Earnings Call Transcript
Biofrontera AG (BFRA) Q4 2019 earnings call dated Apr. 21, 2020 Corporate Participants: Pamela Keck -- Investor Relations Hermann Lubbert -- Chief Executive Officer Thomas Schaffer -- Chief
Pandemic keeps Rite Aid (RAD) busy after mixed Q4; underlying weakness to persist
Rite Aid Corporation (NYSE: RAD) recently witnessed a spurt in store traffic as people rushed to stock up on medicines amid disruptions
Johnson & Johnson retaining Dividend King status lifts the overall mood of the economy
Until a couple of days back, we could only speculate on the impact of COVID-19 on the economy. Of course, the record
Rite Aid (RAD) Q4 Earnings: Key quarterly numbers and other highlights
Rite Aid (NYSE: RAD) reported its fourth quarter financial results for the period ended February 29, 2020. Rite Aid currently has liquidity
Stock Analysis: COVID-19 testing kit gives Abbott (ABT) an edge over Boston Scientific (BSX)
When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one industry that
What’s in store for Rite Aid (RAD) Q4 earnings?
Drugstore chain Rite Aid (NYSE: RAD) is slated to report its fourth-quarter and full-year 2020 results on Thursday, April 16 after the
IPOs filed in the first three months of 2020
2019 was a great year for the IPO market in which more than 200 companies went public in the US. The notable
Cardinal Health Inc (NYSE: CAH) Q2 2020 Earnings Call Transcript
Cardinal Health Inc (CAH) Q2 2020 earnings call dated Feb. 06, 2020 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike Kaufmann -- Chief
Rite Aid (RAD) stock retreats on recession, growth concerns
The concerns have been mounting for Rite Aid Corporation (NYSE: RAD) as the fight against the raging COVID-19 pandemic has lessened the
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Q1 2020 Earnings Call Transcript
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Q1 2020 Earnings Conference Call February 05, 2020 Corporate participants: Vincent Anzalone -- Vice President of Investor Relations
Walgreens Boots (WBA) Q2 2020 earnings call highlights: expects low traffic to hit sales in Q3
Shares of Walgreens Boots Alliance (WBA) made modest gains early Thursday after the company reported stronger-than-expected earnings for the second quarter. Earlier
Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q4 2019 Earnings Call Transcript
Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Morgan Sanford -- Director of Investor Relations Ludwig Hantson -- Chief Executive
Walgreens Boots Alliance (NASDAQ: WBA) Q2 2020 Earnings Call Transcript
Walgreens Boots Alliance Inc (NASDAQ: WBA) Q2 2020 Earnings Conference CallApr. 02, 2020 Corporate Participants: Gerald Gradwell -- Investor Relations Stefano Pessina -- Executive Vice Chairman &
INFOGRAPHIC: Walgreens Boots Alliance (WBA) Q2 2020 sales up 4%
Walgreens Boots Alliance (NASDAQ: WBA) reported second-quarter 2020 earnings on Thursday, April 2, before the opening bell. The company's shares gained immediately
Walgreens Boots Alliance Inc (NASDAQ: WBA) Q1 2020 Earnings Call Transcript
Walgreens Boots Alliance Inc (NASDAQ: WBA) Q1 2020 Earnings Conference Call January 08, 2020 Corporate Participants: Gerald Gradwell -- Senior Vice President of Special Projects
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2019 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2019 Earnings Conference Call Feb. 06, 2020 Corporate participants: Justin Holko -- Investor Relations Leonard S.
Merck & Co Inc (NYSE: MRK) Q4 2019 Earnings Call Transcript
Merck & Co Inc (NYSE: MRK) Q4 2019 Earnings Conference Call February 05, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Call Transcript
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Conference Call February 07, 2020 Corporate Participants: Liz Shea -- Vice President of Investor Relations Richard A. Gonzalez -- Chairman
Titan Pharmaceuticals, Inc. (TTNP): Q4 2019 Earnings Snapshot
— Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported a loss of $0.08 per share in the fourth quarter of 2019, in line with